Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
24.25
-0.13 (-0.53%)
At close: May 9, 2025, 4:00 PM
24.30
+0.05 (0.21%)
After-hours: May 9, 2025, 7:59 PM EDT
Moderna Employees
Moderna had 5,800 employees as of December 31, 2024. The number of employees increased by 200 or 3.57% compared to the previous year.
Employees
5,800
Change (1Y)
200
Growth (1Y)
3.57%
Revenue / Employee
n/a
Profits / Employee
n/a
Market Cap
9.38B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 5,800 | 200 | 3.57% |
Dec 31, 2023 | 5,600 | 1,700 | 43.59% |
Dec 31, 2022 | 3,900 | 1,200 | 44.44% |
Dec 31, 2021 | 2,700 | 1,400 | 107.69% |
Dec 31, 2020 | 1,300 | 470 | 56.63% |
Dec 31, 2019 | 830 | 70 | 9.21% |
Dec 31, 2018 | 760 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
MRNA News
- 2 days ago - Moderna to Present at Upcoming Bernstein's 41st Annual Strategic Decisions Conference (SDC) on May 29, 2025 - Accesswire
- 8 days ago - Moderna: Regulatory Hurdles And Market Challenges Prompt Downgrade To Sell - Seeking Alpha
- 8 days ago - Moderna Expands Cost-Cutting Program By Up To $1.7 Billion, FDA Approval For Flu/COVID-19 Combo Shot Delayed Into 2026 - Benzinga
- 8 days ago - Moderna, Inc. (MRNA) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 9 days ago - Moderna Posts Loss, Citing Seasonality of Respiratory Business - WSJ
- 9 days ago - Moderna beats Wall Street estimates for first-quarter profit and sales - Reuters
- 9 days ago - Moderna Reports First Quarter 2025 Financial Results and Provides Business Updates - Accesswire
- 9 days ago - Moderna Earnings Arrive During a Tough Time for the Stock - Barrons